220 related articles for article (PubMed ID: 15239100)
1. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
[TBL] [Abstract][Full Text] [Related]
2. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
3. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
6. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
Chesire DR; Isaacs WB
Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
[TBL] [Abstract][Full Text] [Related]
7. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
[TBL] [Abstract][Full Text] [Related]
10. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y; Sills RC; Houle CD
Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
[TBL] [Abstract][Full Text] [Related]
11. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
12. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
Hu MC; Rosenblum ND
Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
[TBL] [Abstract][Full Text] [Related]
13. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.
Cha MY; Kim CM; Park YM; Ryu WS
Hepatology; 2004 Jun; 39(6):1683-93. PubMed ID: 15185310
[TBL] [Abstract][Full Text] [Related]
16. STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.
Lee HS; Lee DC; Park MH; Yang SJ; Lee JJ; Kim DM; Jang Y; Lee JH; Choi JY; Kang YK; Kim DI; Park KC; Kim SY; Yoo HS; Choi EJ; Yeom YI
Biochem Biophys Res Commun; 2006 Jul; 345(3):1059-67. PubMed ID: 16712787
[TBL] [Abstract][Full Text] [Related]
17. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
18. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation.
Spychala J; Kitajewski J
Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841
[TBL] [Abstract][Full Text] [Related]
19. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
20. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C
Cancer Res; 2001 Apr; 61(8):3245-9. PubMed ID: 11309273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]